• 1
    Reaven, GM. (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 15951607.
  • 2
    Smith, E. P., Boyd, J., Frank, G. R., et al (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 331: 10561061.
  • 3
    Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., Qin, K. (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 80: 36893698.
  • 4
    Carani, C., Qin, K., Simoni, M., et al (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med. 337: 9195.
  • 5
    Bilezikian, J. P., Morishima, A., Bell, J., Grumbach, MM. (1998) Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med. 339: 599603.
  • 6
    Maffei, L., Murata, Y., Rochira, V., et al (2004) Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab. 89: 6170.
  • 7
    Heine, P. A., Taylor, J. A., Iwamoto, G. A., Lubahn, D. B., Cooke, PS. (2000) Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 97: 1272912734.
  • 8
    Ohlsson, C., Hellberg, N., Parini, P., et al (2000) Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun. 278: 640645.
  • 9
    Marin, P., Lonn, L., Andersson, B., et al (1996) Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone. J Clin Endocrinol Metab. 81: 10181022.
  • 10
    Sato, T., Matsumoto, T., Yamada, T., Watanabe, T., Kawano, H., Kato, S. (2003) Late onset of obesity in male androgen receptor-deficient (AR KO) mice. Biochem Biophys Res Commun. 300: 167171.
  • 11
    Kawano, H., Sato, T., Yamada, T., et al (2003) Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci USA 100: 94169421.
  • 12
    Dunaif, A., Graf, M., Mandeli, J., Laumas, V., Dobrjansky, A. (1987) Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab. 65: 499507.
  • 13
    Vandenput, L., Boonen, S., Van Herck, E., Swinnen, J. V., Bouillon, R., Vanderschueren, D. (2002) Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone. J Bone Miner Res. 17: 20802086.
  • 14
    Dukes, M., Edwards, P. N., Large, M., Smith, I. K., Boyle, T. (1996) The preclinical pharmacology of “Arimidex” (anastrozole; ZD1033)—a potent, selective aromatase inhibitor. J Steroid Biochem Mol Biol. 58: 439445.
  • 15
    Movérare, S., Venken, K., Eriksson, A. L., et al (2003) Differential effects on bone of estrogen receptor alpha and androgen receptor activation in orchidectomized adult male mice. Proc Natl Acad Sci USA 100: 1357313578.
  • 16
    Lubahn, D. B., Moyer, J. S., Golding, T. S., Couse, J. F., Korach, K. S., Smithies, O. (1993) Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 90: 1116211166.
  • 17
    Consolazio, C. F., Johnson, R. E., Pecora, LJ. (1963) Physiological Measurements of Metabolic Functions in Man McGraw Hill New York.
  • 18
    Linden, D., Alsterholm, M., Wennbo, H., Oscarsson, J. (2001) PPARalpha deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins. J Lipid Res. 42: 18311840.
  • 19
    Couse, J. F., Korach, KS. (1999) Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev. 20: 358417.
  • 20
    Ness, G. C., Chambers, CM. (2000) Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity. Proc Soc Exp Biol Med. 224: 819.
  • 21
    Santamarina-Fojo, S., Haudenschild, C., Amar, M. (1998) The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol. 9: 211219.
  • 22
    Simpson, ER. (2002) Aromatization of androgens in women: current concepts and findings. Fertil Steril. 77: (Suppl 4), S6S10.
  • 23
    Jones, M. E., Thorburn, A. W., Britt, K. L., et al (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97: 1273512740.
  • 24
    Seidell, J. C., Muller, D. C., Sorkin, J. D., Andres, R. (1992) Fasting respiratory exchange ratio and resting metabolic rate as predictors of weight gain: the Baltimore Longitudinal Study on Aging. Int J Obes Relat Metab Disord. 16: 667674.
  • 25
    Zurlo, F., Lillioja, S., Esposito-Del Puente, A., et al (1990) Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol. 259: E650E657.
  • 26
    Yu, X. X., Lewin, D. A., Forrest, W., Adams, SH. (2002) Cold elicits the simultaneous induction of fatty acid synthesis and beta-oxidation in murine brown adipose tissue: prediction from differential gene expression and confirmation in vivo. FASEB J. 16: 155168.
  • 27
    Hamilton, B. S., Paglia, D., Kwan, A. Y., Deitel, M. (1995) Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med. 1: 953956.
  • 28
    Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, JM. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425432.
  • 29
    Ogawa, Y., Masuzaki, H., Isse, N., et al (1995) Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (. J Clin Invest. 96: 16471652.
  • 30
    Collins, S., Surwit, RS. (1996) Pharmacologic manipulation of ob expression in a dietary model of obesity. J Biol Chem. 271: 94379440.
  • 31
    Funahashi, T., Shimomura, I., Hiraoka, H., et al (1995) Enhanced expression of rat obese (ob) gene in adipose tissues of ventromedial hypothalamus (VMH)-lesioned rats. Biochem Biophys Res Commun. 211: 469475.
  • 32
    Zitzmann, M., Gromoll, J., von Eckardstein, A., Nieschlag, E. (2003) The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia 46: 3139.
  • 33
    Jones, M. E., Thorburn, A. W., Britt, K. L., et al (2001) Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. J Steroid Biochem Mol Biol. 79: 39.
  • 34
    Sims, N. A., Clement-Lacroix, P., Minet, D., et al (2003) A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. J Clin Invest. 111: 13191327.
  • 35
    Weihua, Z., Lathe, R., Warner, M., Gustafsson, JA. (2002) An endocrine pathway in the prostate, ERbeta AR, 5alpha-androstane-3beta, 17beta-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci USA 99: 1358913594.
  • 36
    Dunaif, A., Thomas, A. (2001) Current concepts in the polycystic ovary syndrome. Annu Rev Med. 52: 401419.
  • 37
    Ibanez, L., Ong, K., Ferrer, A., Amin, R., Dunger, D., de Zegher, F. (2003) Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism. J Clin Endocrinol Metab. 88: 26002606.
  • 38
    Ueda, Y., Royer, L., Gong, E., et al (1999) Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J Biol Chem. 274: 71657171.
  • 39
    Trigatti, B., Rayburn, H., Vinals, M., et al (1999) Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci USA 96: 93229327.
  • 40
    von Eckardstein, A. (1998) Androgens, Cardiovascular Risk Factors, and Atherosclerosis 2nd ed. Springer New York.
  • 41
    Alexandersen, P., Haarbo, J., Christiansen, C. (1996) The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 125: 113.
  • 42
    Whitsel, E. A., Boyko, E. J., Matsumoto, A. M., Anawalt, B. D., Siscovick, DS. (2001) Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. Am J Med. 111: 261269.
  • 43
    Zitzmann, M., Brune, M., Kornmann, B., et al (2001) The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocrinol Metab. 86: 48674873.
  • 44
    Krieger, M. (1999) Charting the fate of the “good cholesterol”: identification and characterization of the high-density lipoprotein receptor SR-BI. Annu Rev Biochem. 68: 523558.
  • 45
    Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., Krieger, M. (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271: 518520.
  • 46
    Langer, C., Gansz, B., Goepfert, C., et al (2002) Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages. Biochem Biophys Res Commun. 296: 10511057.
  • 47
    Elam, M. B., Umstot, E. S., Andersen, R. N., Solomon, S. S., Heimberg, M. (1987) Deprivation and repletion of androgen in vivo modifies triacylglycerol synthesis by rat hepatocytes. Biochim Biophys Acta 921: 531540.
  • 48
    Watkins, M. L., Fizette, N., Heimberg, M. (1972) Sexual influences on hepatic secretion of triglyceride. Biochim Biophys Acta 280: 8285.
  • 49
    Tietge, U. J., Bakillah, A., Maugeais, C., Tsukamoto, K., Hussain, M., Rader, DJ. (1999) Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J Lipid Res. 40: 21342139.
  • 50
    Miyazaki, M., Kim, Y. C., Gray-Keller, M. P., Attie, A. D., Ntambi, JM. (2000) The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J Biol Chem. 275: 3013230138.
  • 51
    Ntambi, J. M., Miyazaki, M., Stoehr, J. P., et al (2002) Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 99: 1148211486.
  • 52
    Kakuma, T., Lee, Y., Unger, RH. (2002) Effects of leptin, troglitazone, and dietary fat on stearoyl CoA desaturase. Biochem Biophys Res Commun. 297: 12591263.
  • 53
    Cohen, JC. (1999) Contribution of cholesterol 7alpha-hydroxylase to the regulation of lipoprotein metabolism. Curr Opin Lipidol. 10: 303307.